Fredericton-based Green Imaging Technologies has appointed Norm Couturier as chief executive officer while Co-Founder Derrick Green has moved into the newly created role of chief technology officer.

The changes took effect July 15 and are intended to give separate executive oversight to the company's commercial operations and technology development.

Couturier had served as chief operating officer for the past two years, overseeing commercial operations. As CEO, he will be responsible for leading the company's business growth while continuing its commercial expansion.

Green, who previously served as CEO, will now focus on technology strategy, research and development, and the company's long-term innovation agenda in his role as CTO.

"This is a transition that reflects the natural and exciting maturation of Green Imaging Technologies," said Board Chair David Wagner in a statement. "The Board has tremendous confidence in both Norm and Derrick. By dedicating our strongest commercial leader to the CEO role and channelling Derrick's extraordinary technology expertise into an elevated CTO mandate, we are positioning GIT to pursue growth and innovation at a pace and depth that a unified executive model simply cannot match.”

Couturier said he plans to build on the company's recent commercial momentum. Green said the CTO position will allow him to concentrate on advancing the company's technology and supporting its engineering and research teams.

Green Imaging Technologies develops Nuclear Magnetic Resonance imaging technology for commercial and industrial applications. The company said it has expanded its customer base, entered new market channels and strengthened its intellectual property portfolio over the past two years.

The company said the revised executive structure is designed to support its next stage of development by separating responsibility for business operations from responsibility for technology leadership.

Founded in Fredericton, Green Imaging Technologies develops proprietary imaging systems based on Nuclear Magnetic Resonance technology for use in a range of industrial and commercial markets. The company said its focus on technology development will remain central to its competitive strategy under the new leadership structure.